SPDR S&P BIOTECH ETF (XBI)

US78464A8707 - ETF

89.98  +1.64 (+1.86%)

After market: 90.26 +0.28 (+0.31%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

SPDR S&P BIOTECH ETF

NYSEARCA:XBI (5/3/2024, 7:27:04 PM)

After market: 90.26 +0.28 (+0.31%)

89.98

+1.64 (+1.86%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap5.45B
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

American Stock Exchange Stock Screener

Find more stocks on American Stock Exchange

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

ETF Stock Screener

Find more ETFs on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

XBI Daily chart

Company Profile

The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.

Company Info

SPDR S&P BIOTECH ETF

XBI News

News Image8 days ago - Market News VideoXBI June 7th Options Begin Trading
News Image9 days ago - InvestorPlace3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition

Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.

News Imagea month ago - InvestorPlace5 Healthcare Stocks to Buy for 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

News Imagea month ago - The Motley Fool3 Top ETFs I Plan to Buy in April

These ETFs are easy, low-cost ways to invest in certain themes.

News Imagea month ago - InvestorPlace3 Biotech Stocks to Buy on the Dip: March 2024

Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.

News Image2 months ago - InvestorPlace3 Biotech ETFs Overdue for a Bounce

The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.

XBI Twits

Here you can normally see the latest stock twits on XBI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example